ArticlePaediatrics & child health2025
A descriptive analysis of autoimmune cytopenias in children with inborn errors of immunity.
Article in Paediatrics & child health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Inborn errors of immunity (IEI) are a heterogenous group of disorders that lead to impairment and dysfunction of one or more parts of the immune system. Autoimmunity and autoimmune cytopenias have increasingly been recognized as early markers of IEI. This study describes the type, severity and range of cytopenias in children with IEI of varying immunophenotypes at a single Canadian centre. Methods: A retrospective chart review was completed of children with IEI followed at the Stollery Children's Hospital in Edmonton, Alberta from January 2015 to December 2022. Patients were included if they received a diagnosis of an IEI and had single or multi-lineage cytopenia(s). The IEI diagnoses were grouped into immunophenotypic categories and cytopenias were compared using descriptive statistics. Results: Immune cytopenias were common in all phenotypic categories, though there was variability in the type and severity. Thrombocytopenia was most likely to be seen in combined (53.8%), syndromic (59%) and immune regulatory disorders (63.6%). Neutropenia was most common in phagocytic (71.4%), immune regulatory (63.7%) and humoral disorders (52.6%). Multi-lineage cytopenias were present in 67.2% of cases and 10.4% had persistent cytopenias. Conclusions: Immune cytopenias are common in varying types of IEI and are not isolated to a specific disease category. When seeing a patient with concerns for IEI, providers should investigate both for features of immunodeficiency and autoimmunity, in particular autoimmune cytopenias. The pattern of cytopenia may favour specific immunophenotypes and help prioritize further testing and timely referral.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.